{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T05:09:49Z","timestamp":1779253789010,"version":"3.51.4"},"reference-count":65,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T00:00:00Z","timestamp":1779235200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Diabetic kidney disease (DKD) is a major cause of end-stage renal disease (ESRD). Early identification of DKD patients at high risk of progressing to ESRD is essential, yet the overall performance, methodological quality, and translational readiness of prediction models for this transition remain unclear. To our knowledge, we conducted the first systematic review and meta-analysis focused specifically on prediction models for progression from established DKD to ESRD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We searched PubMed, Embase, Cochrane Library, Web of Science, China National Knowledge Infrastructure (CNKI), Wanfang, VIP Chinese Journal Service Platform, and the Chinese Biomedical Literature Database (CBM) for English- and Chinese-language studies published through 27 September 2025 that developed or validated DKD to ESRD prediction models. Two reviewers independently screened records and extracted data. Risk of bias was assessed using the updated PROBAST-AI checklist. Reported AUCs were pooled using random-effects meta-analysis (Stata 18.0) with 95% confidence intervals (CIs). We performed sensitivity analyses, assessed publication bias, and conducted subgroup analyses by inclusion of pathological predictors and prediction horizon.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Fifteen studies met inclusion criteria. PROBAST-AI judged all 15 studies at high risk of bias, mainly due to retrospective single-center designs, lack of blinded predictor assessment, use of predictors not routinely available in practice, and inadequate calibration and external validation; seven studies were limited to biopsy-proven DKD, limiting their applicability to routine clinical populations. Meta-analysis included training datasets from six studies (seven models) and validation datasets from three studies (three models). Pooled AUCs were 0.896 (95% CI, 0.853\u20130.940) for training models and 0.863 (95% CI, 0.803\u20130.923) for validation models. Five prespecified sensitivity analyses yielded broadly similar pooled AUCs, but interpretation remained exploratory because of persistent heterogeneity and universal high risk of bias. Subgroup analyses found no significant differences by pathological predictor inclusion or prediction horizon.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Published DKD to ESRD models show promising discrimination in development and internal validation cohorts. However, pervasive methodological limitations, extreme heterogeneity, and scarce independent external validation severely restrict clinical generalizability. Prespecified sensitivity analyses yielded broadly similar pooled AUCs, but these results remain exploratory. Future prospective multicenter studies with rigorous external validation and calibration are urgently needed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Systematic Review Registration<\/jats:title>\n                    <jats:p>\n                      <jats:ext-link>https:\/\/www.crd.york.ac.uk\/prospero\/display_record.php?ID=CRD420251127778<\/jats:ext-link>\n                      , identifier CRD420251127778.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fendo.2026.1812362","type":"journal-article","created":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T04:47:18Z","timestamp":1779252438000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Prediction models for progression from diabetic kidney disease to end-stage renal disease: a systematic review and meta-analysis"],"prefix":"10.3389","volume":"17","author":[{"given":"Yang","family":"Shi","sequence":"first","affiliation":[{"name":"Treatment Center of Kidney Disease, The First Affiliated Hospital of Henan University of Chinese Medicine","place":["Zhengzhou, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhaoxi","family":"Dong","sequence":"additional","affiliation":[{"name":"Dongzhimen Hospital, Beijing University of Chinese Medicine","place":["Beijing, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaomeng","family":"Shan","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, The First Affiliated Hospital of Henan University of Chinese Medicine","place":["Zhengzhou, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiqian","family":"Wang","sequence":"additional","affiliation":[{"name":"Treatment Center of Kidney Disease, The First Affiliated Hospital of Henan University of Chinese Medicine","place":["Zhengzhou, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Siyu","family":"Huang","sequence":"additional","affiliation":[{"name":"Treatment Center of Kidney Disease, The First Affiliated Hospital of Henan University of Chinese Medicine","place":["Zhengzhou, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongfang","family":"Liu","sequence":"additional","affiliation":[{"name":"Dongzhimen Hospital, Beijing University of Chinese Medicine","place":["Beijing, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linqi","family":"Zhang","sequence":"additional","affiliation":[{"name":"Treatment Center of Kidney Disease, The First Affiliated Hospital of Henan University of Chinese Medicine","place":["Zhengzhou, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,5,20]]},"reference":[{"key":"B1","article-title":"Idf diabetes atlas","volume-title":"IDF diabetes atlas","author":"Magliano","year":"2021"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1097\/cm9.0000000000003428","article-title":"Epidemiological status, development trends, and risk factors of disability-adjusted life years due to diabetic kidney disease: A systematic analysis of Global Burden of Disease Study 2021","volume":"138","author":"Li","year":"2025","journal-title":"Chin Med J (Engl)"},{"key":"B3","volume-title":"2024 USRDS Annual Data Report: Epidemiology of kidney disease in the United States","year":"2024"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.2337\/cd23-0063","article-title":"Diabetic kidney disease prevention care model development","volume":"42","author":"ElSayed","year":"2024","journal-title":"Clin Diabetes"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.mcpdig.2025.100228","article-title":"Implementation and updating of clinical prediction models: A systematic review","volume":"3","author":"Saelmans","year":"2025","journal-title":"Mayo Clin Proc Digit Health"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2023-078276","article-title":"Developing clinical prediction models: a step-by-step guide","volume":"386","author":"Efthimiou","year":"2024","journal-title":"Bmj"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.81878","article-title":"Prediction of diabetic kidney disease risk using machine learning models: A population-based cohort study of Asian adults","volume":"12","author":"Sabanayagam","year":"2023","journal-title":"Elife"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1080\/0886022x.2022.2056053","article-title":"Development and internal validation of machine learning algorithms for end-stage renal disease risk prediction model of people with type 2 diabetes mellitus and diabetic kidney disease","volume":"44","author":"Zou","year":"2022","journal-title":"Ren Fail"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2011.451","article-title":"A predictive model for progression of chronic kidney disease to kidney failure","volume":"305","author":"Tangri","year":"2011","journal-title":"Jama"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2024.1407348","article-title":"Risk prediction models for diabetic nephropathy among type 2 diabetes patients in China: a systematic review and meta-analysis","volume":"15","author":"Xu","year":"2024","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1080\/0886022x.2024.2435483","article-title":"Artificial intelligence in predicting chronic kidney disease prognosis. A systematic review and meta-analysis","volume":"46","author":"Pan","year":"2024","journal-title":"Ren Fail"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"Bmj"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1001744","article-title":"Critical appraisal and data extraction for systematic reviews of prediction modelling studies: the CHARMS checklist","volume":"11","author":"Moons","year":"2014","journal-title":"PloS Med"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2024-082505","article-title":"PROBAST+AI: an updated quality, risk of bias, and applicability assessment tool for prediction models using regression or artificial intelligence methods","volume":"388","author":"Moons","year":"2025","journal-title":"Bmj"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"Bmj"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n2281","article-title":"Risk of bias in studies on prediction models developed using supervised machine learning techniques: systematic review","volume":"375","author":"Andaur Navarro","year":"2021","journal-title":"Bmj"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.i6460","article-title":"A guide to systematic review and meta-analysis of prediction model performance","volume":"356","author":"Debray","year":"2017","journal-title":"Bmj"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.4103\/tjem.tjem_182_23","article-title":"Receiver operating characteristic curve analysis in diagnostic accuracy studies: A guide to interpreting the area under the curve value","volume":"23","author":"\u00c7orbac\u0131o\u011flu","year":"2023","journal-title":"Turk J Emerg Med"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"Bmj"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2025.1481977","article-title":"Clinical significance of hyperuricaemia in biopsy-proven diabetic kidney disease - a single-centre retrospective study","volume":"16","author":"Yu","year":"2025","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.8499","article-title":"Development and validation of a predictive model for end-stage renal disease risk in patients with diabetic nephropathy confirmed by renal biopsy","volume":"8","author":"Sun","year":"2020","journal-title":"PeerJ"},{"key":"B22","article-title":"Influencing factors and the development and validation of a predictive model of the progression of diabetic kidney disease","volume-title":"Zhengzhou univ","author":"Cheng","year":"2020"},{"key":"B23","article-title":"Establishment of a prognostic model for diabetic nephropathy based on artificial intelligence","volume-title":"Peking union med coll","author":"Wang","year":"2022"},{"key":"B24","article-title":"The risk factors of diabetic nephropathy progression and establishment of prediction equation","volume-title":"Lanzhou univ","author":"He","year":"2021"},{"key":"B25","article-title":"Construction and verification of prediction model of diabetic nephropathy progressing to end-stage renal disease","volume-title":"Jiangxi univ chin med","author":"Zhou","year":"2023"},{"key":"B26","article-title":"Clinical study on the relationship between serum 25 (OH) vitamin D level and the progression of type 2 diabetic nephropathy","volume-title":"Nanchang univ","author":"Xue","year":"2023"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2025.1532494","article-title":"Development of a nomogram for predicting renal survival in patients with biopsy-proven diabetic nephropathy","volume":"16","author":"Lin","year":"2025","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.2147\/dmso.S500992","article-title":"Development of predictive models for progression from diabetic kidney disease to end-stage renal disease in type 2 diabetes mellitus: A retrospective cohort study","volume":"18","author":"Hu","year":"2025","journal-title":"Diabetes Metab Syndr Obes"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1136\/bmjdrc-2024-004282","article-title":"Investigation of end-stage kidney disease risk prediction in an ethnically diverse cohort of people with type 2 diabetes: use of kidney failure risk equation","volume":"12","author":"Goubar","year":"2024","journal-title":"BMJ Open Diabetes Res Care"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1159\/000431333","article-title":"A pathological scoring system to predict renal outcome in diabetic nephropathy","volume":"41","author":"Hoshino","year":"2015","journal-title":"Am J Nephrol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.21037\/apm-21-1454","article-title":"Prognostic evaluation model of diabetic nephropathy patients","volume":"10","author":"Tu","year":"2021","journal-title":"Ann Palliat Med"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.2215\/cjn.01381005","article-title":"Risk scores for predicting outcomes in patients with type 2 diabetes and nephropathy: the RENAAL study","volume":"1","author":"Keane","year":"2006","journal-title":"Clin J Am Soc Nephrol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0190930","article-title":"Value of adding the renal pathological score to the kidney failure risk equation in advanced diabetic nephropathy","volume":"13","author":"Yamanouchi","year":"2018","journal-title":"PloS One"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1080\/0886022x.2021.2009862","article-title":"Addition of glomerular lesion severity improves the value of anemia status for the prediction of renal outcomes in Chinese patients with type 2 diabetes","volume":"44","author":"Zhao","year":"2022","journal-title":"Ren Fail"},{"key":"B35","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1016\/j.kint.2023.10.016","article-title":"Executive summary of the KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease: known knowns and known unknowns","volume":"105","author":"Levin","year":"2024","journal-title":"Kidney Int"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1681\/asn.2004100854","article-title":"Detection of renal function decline in patients with diabetes and normal or elevated GFR by serial measurements of serum cystatin C concentration: results of a 4-year follow-up study","volume":"16","author":"Perkins","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2016.10.046","article-title":"Fast renal decline to end-stage renal disease: an unrecognized feature of nephropathy in diabetes","volume":"91","author":"Krolewski","year":"2017","journal-title":"Kidney Int"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1111\/j.1523-1755.2004.00863.x","article-title":"Anemia and end-stage renal disease in patients with type 2 diabetes and nephropathy","volume":"66","author":"Mohanram","year":"2004","journal-title":"Kidney Int"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.3390\/nu14112317","article-title":"Prognostic value of the controlling nutritional status (CONUT) score in patients at dialysis initiation","volume":"14","author":"Takagi","year":"2022","journal-title":"Nutrients"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1093\/ckj\/sfac004","article-title":"New-onset anemia and associated risk of ESKD and death in non-dialysis CKD patients: a multicohort observational study","volume":"15","author":"Minutolo","year":"2022","journal-title":"Clin Kidney J"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2023.1231448","article-title":"Controlling nutritional status score is associated with renal progression, cardiovascular events, and all-cause mortality in biopsy-proved diabetic kidney disease","volume":"14","author":"Huo","year":"2023","journal-title":"Front Physiol"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1038\/s41581-019-0234-4","article-title":"Innate immunity in diabetic kidney disease","volume":"16","author":"Tang","year":"2020","journal-title":"Nat Rev Nephrol"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.2147\/dmso.S447026","article-title":"Association of systemic immune-inflammation index and systemic inflammation response index with diabetic kidney disease in patients with type 2 diabetes mellitus","volume":"17","author":"Liu","year":"2024","journal-title":"Diabetes Metab Syndr Obes"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2021.713652","article-title":"Serum uric acid and kidney disease measures independently predict cardiovascular and total mortality: the uric acid right for heart health (URRAH) project","volume":"8","author":"Russo","year":"2021","journal-title":"Front Cardiovasc Med"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1007\/s13300-023-01374-9","article-title":"Hyperuricemia predicts the progression of type 2 diabetic kidney disease in chinese patients","volume":"14","author":"Zhu","year":"2023","journal-title":"Diabetes Ther"},{"key":"B46","doi-asserted-by":"publisher","first-page":"6251","DOI":"10.1038\/s41598-022-10118-x","article-title":"A systematic review and meta-analysis of the association between uric acid levels and chronic kidney disease","volume":"12","author":"Gon\u00e7alves","year":"2022","journal-title":"Sci Rep"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1093\/ckj\/sfad131","article-title":"Relationship of serum lipid parameters with kidney function decline accompanied by systemic arterial stiffness: a retrospective cohort study","volume":"16","author":"Nagayama","year":"2023","journal-title":"Clin Kidney J"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfad118","article-title":"Hypertension in chronic kidney disease-treatment standard 2023","volume":"38","author":"Georgianos","year":"2023","journal-title":"Nephrol Dial Transplant"},{"key":"B49","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1186\/s12882-020-01943-1","article-title":"Renal histology in diabetic nephropathy predicts progression to end-stage kidney disease but not the rate of renal function decline","volume":"21","author":"Misra","year":"2020","journal-title":"BMC Nephrol"},{"key":"B50","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1186\/s12916-019-1466-7","article-title":"Calibration: the Achilles heel of predictive analytics","volume":"17","author":"Van Calster","year":"2019","journal-title":"BMC Med"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1681\/asn.2020071077","article-title":"Kidney failure prediction models: a comprehensive external validation study in patients with advanced CKD","volume":"32","author":"Ramspek","year":"2021","journal-title":"J Am Soc Nephrol"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2025.103602","article-title":"Epilepsy prediction models for children and adolescents: a systematic review and meta-analysis","volume":"90","author":"Luo","year":"2025","journal-title":"EClinicalMedicine"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2015.18202","article-title":"Multinational assessment of accuracy of equations for predicting risk of kidney failure: a meta-analysis","volume":"315","author":"Tangri","year":"2016","journal-title":"Jama"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-024-07480-x","article-title":"Heterogeneity in the definition of major adverse kidney events: a scoping review","volume":"50","author":"Maeda","year":"2024","journal-title":"Intensive Care Med"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2020.12.006","article-title":"Importance of standardizing renal outcomes in clinical trials: illustration by recent sodium glucose cotransporter 2 inhibitor studies","volume":"99","author":"van Raalte","year":"2021","journal-title":"Kidney Int"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1016\/j.xkme.2024.100889","article-title":"Kidney biopsy findings among patients with diabetes in the Cleveland Clinic Kidney Biopsy Epidemiology Project","volume":"6","author":"Kwon","year":"2024","journal-title":"Kidney Med"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1007\/s13300-020-00888-w","article-title":"Insights into the role of renal biopsy in patients with T2DM: a literature review of global renal biopsy results","volume":"11","author":"Tong","year":"2020","journal-title":"Diabetes Ther"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1136\/bmjdrc-2022-003058","article-title":"Prevalence of non-diabetic kidney disease and inability of clinical predictors to differentiate it from diabetic kidney disease: results from a prospectively performed renal biopsy study","volume":"10","author":"Basu","year":"2022","journal-title":"BMJ Open Diabetes Res Care"},{"key":"B59","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.ekir.2020.10.019","article-title":"A systematic review of complications associated with percutaneous native kidney biopsies in adults in low- and middle-income countries","volume":"6","author":"Kajawo","year":"2021","journal-title":"Kidney Int Rep"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.2215\/cjn.05750515","article-title":"The native kidney biopsy: update and evidence for best practice","volume":"11","author":"Hogan","year":"2016","journal-title":"Clin J Am Soc Nephrol"},{"key":"B61","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1186\/s12874-016-0267-3","article-title":"No rationale for 1 variable per 10 events criterion for binary logistic regression analysis","volume":"16","author":"van Smeden","year":"2016","journal-title":"BMC Med Res Methodol"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.m441","article-title":"Calculating the sample size required for developing a clinical prediction model","volume":"368","author":"Riley","year":"2020","journal-title":"Bmj"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.g7594","article-title":"Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD statement","volume":"350","author":"Collins","year":"2015","journal-title":"Bmj"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2023-078378","article-title":"TRIPOD+AI statement: updated guidance for reporting clinical prediction models that use regression or machine learning methods","volume":"385","author":"Collins","year":"2024","journal-title":"Bmj"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2018.01.009","article-title":"Predicting timing of clinical outcomes in patients with chronic kidney disease and severely decreased glomerular filtration rate","volume":"93","author":"Grams","year":"2018","journal-title":"Kidney Int"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1812362\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T04:47:43Z","timestamp":1779252463000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1812362\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,20]]},"references-count":65,"alternative-id":["10.3389\/fendo.2026.1812362"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2026.1812362","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,20]]},"article-number":"1812362"}}